trans-3-Methyl-4-octanolide
Common Name: |
trans-3-Methyl-4-octanolide |
IUPAC Name: |
(4S,5R)-5-butyl-4-methyloxolan-2-one |
Molecular Formula: |
C10H20O2 |
SMILES: |
CCCCC1C(CC(=O)O1)C |
Inchi: |
1S/C9H16O2/c1-3-4-5-8-7(2)6-9(10)11-8/h7-8H,3-6H2,1-2H3/t7-,8+/m0/s1 |
Inchi Key: |
WNVCMFHPRIBNCW-JGVFFNPUSA-N |
Cas No: |
80041-01-6 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
172.26 |
Mass (g/mol) |
156.115 |
Molar Refractivity |
50.24 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
4 |
Rings |
1 |
TPSA |
18.46 |
Hetero Atoms |
2 |
Heavy Atoms |
12 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
246.52 |
Vapor Pressure (mmHg@25.00 °C) |
0.027 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
1.00 |
LogP |
2.128 |
iLOGP |
3.03 |
XLOGP3 |
3.07 |
WLOGP |
2.72 |
MLOGP |
1.93 |
ESOL Log S |
-2.58 |
ESOL Solubility (mg/ml) |
0.455 |
ESOL Solubility (mol/l) |
0.003 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.12 |
Ali Solubility (mg/ml) |
0.13 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.27 |
Silicos-IT Solubility (mg/ml) |
0.92 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.17 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.804 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.045 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |